BioLyo Technologies, BV is a wholly-owned ILiAD subsidiary based in Ghent, Belgium. The contract development manufacturing organization (CDMO), led by Marcel Thalen, PhD, currently provides process development for live biologicals, with an initial focus on B-Tech process development.
BioLyo offers an integrated approach to process development, focusing on developing a process where each of the process steps are geared towards maximal survival and stability after lyophilization, from medium optimization to Drug Product formulation. Link to website.